| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9098143 | Journal Européen des Urgences | 2005 | 6 Pages |
Abstract
Our study provides some evidence that the early administration of abciximab in the ED is safe and feasible and justified by the delay required for coronary revascularization.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
A. Arhan, P. Ecollan, B. Madonna-Py, J. Kergueno, M. Bennaceur, M.-O. Josse, G. Montalescot, B. Riou,